Ph.D. Kiernan Seth

Insider Reports History

Location
The Woodlands, TX
Signature
/s/ Kiernan Seth, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ph.D. Kiernan Seth:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. VP, Chief Commercial Officer Common Stock 53,136 $55,968 $1.05 28 Feb 2023 Direct
LEXICON PHARMACEUTICALS, INC. VP, Chief Commercial Officer Restricted Stock Units 45,927 $48,375 $1.05 28 Feb 2023 Direct
LEXICON PHARMACEUTICALS, INC. VP, Chief Commercial Officer Stock Option (Right to Buy) 280,100 09 Feb 2023 Direct

Insider Reports Filed by Ph.D. Kiernan Seth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2023 7 -$25,634 4 VP, Chief Commercial Officer 01 Mar 2023, 15:55
LXRX LEXICON PHARMACEUTICALS, INC. 09 Feb 2023 2 $0 4 VP, Chief Commercial Officer 13 Feb 2023, 16:04
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2022 7 -$23,544 4 VP, Chief Commercial Officer 28 Feb 2022, 18:17
LXRX LEXICON PHARMACEUTICALS, INC. 10 Feb 2022 2 $0 4 VP, Chief Commercial Officer 14 Feb 2022, 15:09
LXRX LEXICON PHARMACEUTICALS, INC. 28 Oct 2021 0 $0 3 VP, Chief Commercial Officer 29 Oct 2021, 16:18